257
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

Serological response following vaccination with BNT162b2 mRNA in patients with chronic lymphocytic leukemia

, , & ORCID Icon
Pages 503-505 | Received 12 Jul 2021, Accepted 16 Aug 2021, Published online: 02 Nov 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Massimiliano Lanzafame, Martina Gottardi, Lorenza Guella, Lucia Collini, Giorgio Costa, Anna Guella & Sandro Vento. (2023) Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients. Journal of Chemotherapy 35:7, pages 623-626.
Read now

Articles from other publishers (4)

Noppacharn Uaprasert, Palada Pitakkitnukun, Nuanrat Tangcheewinsirikul, Thita Chiasakul & Ponlapat Rojnuckarin. (2022) Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis. Blood Cancer Journal 12:12.
Crossref
Carsten U. Niemann, Caspar da Cunha-Bang, Marie Helleberg, Sisse R. Ostrowski & Christian Brieghel. (2022) Patients with CLL have a lower risk of death from COVID-19 in the Omicron era. Blood 140:5, pages 445-450.
Crossref
Sibylle C. Mellinghoff, Sandra Robrecht, Leonie Mayer, Leonie M. Weskamm, Christine Dahlke, Henning Gruell, Kanika Vanshylla, Hans A. Schlösser, Martin Thelen, Anna-Maria Fink, Kirsten Fischer, Florian Klein, Marylyn M. Addo, Barbara Eichhorst, Michael Hallek & Petra Langerbeins. (2021) SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia. Leukemia 36:2, pages 562-565.
Crossref
Carsten U. Niemann, Farrukh T. Awan, Laura Fogliatto, Eugene Nikitin, Olga Samoilova, Adel Habib, Kayhan Foroutanpour, Nataliya Kuptsova-Clarkson & Stephen Opat. (2022) COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study. HemaSphere 6:10, pages e780.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.